Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Ketoprocen 300 mg/ml V/DCP/21/0036 Cenavisa S.L, Spānija QM01AE03 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for use in drinking water
International name (active substance): Ketoprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0036-01 1 ABPE pudele, 500 ml -
Colivet oral solution - V/NRP/03/1617 Ceva Sante Animale', Francija QA07AA10 poultry; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Colistin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 22-Oct-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1617-01 1 Polietilēna flakons, 250 ml -
V/NRP/03/1617-02 1 Polietilēna flakons, 500 ml -
V/NRP/03/1617-03 1 Polietilēna flakons, 1 l -
V/NRP/03/1617-04 1 Polietilēna flakons, 2 l -
V/NRP/03/1617-05 1 Polietilēna flakons, 5 l -
CYLANIC - V/DCP/21/0041 Industrial Veterinaria, S.A., Spānija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 24102025LI (24-Oct-2025)
Labelling text: [DOCX] 24102025M (24-Oct-2025)
Summary of product characteristics: [DOCX] 24102025ZA (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0041-01 1 Blisteris, 10 tablete -
V/DCP/21/0041-02 3 Blisteris, 10 tablete -
V/DCP/21/0041-03 5 Blisteris, 10 tablete -
V/DCP/21/0041-04 10 Blisteris, 10 tablete -
V/DCP/21/0041-05 25 Blisteris, 10 tablete -
CYLANIC - V/DCP/21/0042 Industrial Veterinaria, S.A., Spānija QJ01CR02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 24102025LI (24-Oct-2025)
Labelling text: [DOCX] 24102025M (24-Oct-2025)
Summary of product characteristics: [DOCX] 24102025ZA (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0042-01 1 Blisteris, 10 tablete -
V/DCP/21/0042-02 3 Blisteris, 10 tablete -
V/DCP/21/0042-03 5 Blisteris, 10 tablete -
V/DCP/21/0042-04 10 Blisteris, 10 tablete -
V/DCP/21/0042-05 25 Blisteris, 10 tablete -
Isaderm - V/NRP/03/1600 Dechra Veterinary Products A/S, Dānija QD07CC01 dogs Vairāk

Medicinal product information

Pharmaceutical form: gel
International name (active substance): Fusidic acid, Betamethasone valerate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release GENERA Inc., Horvātija
Date of authorisation/renewal: 08-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1600-01 1 Alumīnija tūba, 15 g -
V/NRP/03/1600-02 1 Alumīnija tūba, 5 g -
V/NRP/03/1600-03 1 Alumīnija tūba, 30 g -
Duelmint 40 - V/NRP/08/1568 Fatro S.p.A., Itālija QP52AC59 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Mebendazole,Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1568-01 1 Plastikāta tūbiņa, 15 ml -
Duelmint 20 - V/NRP/02/1489 Fatro S.p.A., Itālija QP52AC59 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Mebendazole,Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1489-01 1 Injektors, 15 ml -
Belacol 100% Compactate 1000 mg/g V/DCP/16/0027 Bela-pharm GmbH&Co.KG, Vācija QA07AA10 cattle; pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: granules for use in drinking water
International name (active substance): Colistin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 27-Oct-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0027-01 1000 mg/g 1 Kastīte, 250 g -
V/DCP/16/0027-02 1000 mg/g 1 Kastīte, 500 g -
V/DCP/16/0027-03 1000 mg/g 1 Kastīte, 1 kg -
V/DCP/16/0027-04 1000 mg/g 1 Kastīte, 2,5 kg -
Bovilis IBR Marker Inac - V/MRP/06/1675 Intervet International B.V., Nīderlande QI02AA03 cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated antigen of BHV-1 (gE) strain GK/D
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 16-Nov-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/06/1675-01 1 Stikla flakons, 5 deva -
V/MRP/06/1675-02 10 Stikla flakons, 5 deva -
V/MRP/06/1675-03 1 Stikla flakons, 10 deva -
V/MRP/06/1675-04 10 Stikla flakons, 10 deva -
V/MRP/06/1675-05 1 Stikla flakons, 25 deva -
V/MRP/06/1675-06 10 Stikla flakons, 25 deva -
V/MRP/06/1675-07 1 Stikla flakons, 50 deva -
V/MRP/06/1675-08 10 Stikla flakons, 50 deva -
V/MRP/06/1675-09 1 Stikla flakons, 100 deva -
V/MRP/06/1675-10 10 Stikla flakons, 100 deva -
V/MRP/06/1675-11 1 Plastmasas flakons, 5 deva -
V/MRP/06/1675-12 10 Plastmasas flakons, 5 deva -
V/MRP/06/1675-13 1 Plastmasas flakons, 10 deva -
V/MRP/06/1675-14 10 Plastmasas flakons, 10 deva -
V/MRP/06/1675-15 1 Plastmasas flakons, 25 deva -
V/MRP/06/1675-16 10 Plastmasas flakons, 25 deva -
V/MRP/06/1675-17 1 Plastmasas flakons, 50 deva -
V/MRP/06/1675-18 10 Plastmasas flakons, 50 deva -
V/MRP/06/1675-19 1 Plastmasas flakons, 100 deva -
V/MRP/06/1675-20 10 Plastmasas flakons, 100 deva -
Amoxibactin vet 50 mg V/DCP/14/0059 Le Vet Beheer B.V., Nīderlande QJ01CA04 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0059-01 50 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/14/0059-02 50 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-03 50 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-04 50 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-05 50 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-06 50 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-07 50 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-08 50 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-09 50 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-10 50 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-11 50 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-12 50 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0059-13 50 mg 10 Kastīte ar blisteri, 10 tablete -
Amoxibactin vet 250 mg V/DCP/14/0060 Le Vet Beheer B.V., Nīderlande QJ01CA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0060-01 250 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-02 250 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-03 250 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-04 250 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-05 250 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-06 250 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-07 250 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-08 250 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-09 250 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-10 250 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-11 250 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-12 250 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0060-13 250 mg 10 Kastīte ar blisteri, 10 tablete -
Amoxibactin vet 500 mg V/DCP/14/0061 Le Vet Beheer B.V., Nīderlande QJ01CA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0061-01 500 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-02 500 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-03 500 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-04 500 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-05 500 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-06 500 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-07 500 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-08 500 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-09 500 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-10 500 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-11 500 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-12 500 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/14/0061-13 500 mg 10 Kastīte ar blisteri, 10 tablete -
Intra Hoof-Fit Gel - V/MRP/13/0017 Intracare BV, Nīderlande QD03 dairy cows Vairāk

Medicinal product information

Pharmaceutical form: gel
International name (active substance): Copper,Zinc
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Intracare BV, Nīderlande
Date of authorisation/renewal: 28-Apr-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0017-01 6 Polipropilēna konteiners, 430 g -
Boflox flavour 20 mg V/DCP/16/0041 Industrial Veterinaria, S.A., Spānija QJ01MA93 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 27-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0041-01 1 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-02 2 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-03 5 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-04 10 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-05 15 Al/Al blisteris, 10 tablete -
V/DCP/16/0041-06 20 Al/Al blisteris, 10 tablete -
Boflox flavour 80 mg V/DCP/16/0042 Industrial Veterinaria, S.A., Spānija QJ01MA93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 27-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0042-01 1 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-02 2 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-03 6 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-04 12 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-05 20 Al/Al blisteris, 6 tablete -
V/DCP/16/0042-06 40 Al/Al blisteris, 6 tablete -
LV Ceftionel-50 50 mg/ml V/NRP/11/0065 Interchemie werken „De Adelaar“ LT, Lietuva QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 26102021LI (26-Oct-2021)
Labelling text: [DOCX] 26102021M (26-Oct-2021)
Summary of product characteristics: [DOCX] 26102021ZA (26-Oct-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/11/0065-01 50 mg/ml 1 Stikla pudele, 50 ml -
V/NRP/11/0065-02 50 mg/ml 1 Stikla pudele, 100 ml -
Depedin - V/NRP/92/0216 Veyx-Pharma GmbH, Vācija QH02AB30 cattle; pigs; horses; dogs; cats; piglets Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Dexamethasone, Prednisolone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
Date of authorisation/renewal: 18-Mar-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOC] 190825LI (19-Aug-2025)
Labelling text: [DOC] 260422M (26-Apr-2022)
Summary of product characteristics: [DOC] 260422ZA (26-Apr-2022)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/92/0216-01 1 Stikla flakons, 50 ml -
V/NRP/92/0216-02 12 Stikla flakons, 50 ml -
Api-Bioxal 0.71 g/g V/MRP/21/0019 Chemicals Laif S.p.A., Itālija QP53AG03 honey bees Vairāk

Medicinal product information

Pharmaceutical form: Powder for in-hive use
International name (active substance): Oxalic acid dihydrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chemifarma S.p.A., Itālija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Jun-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Jun-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Jun-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0019-01 0,71 g/g 1 Maisiņš, 35 g -
V/MRP/21/0019-02 0,71 g/g 1 Maisiņš, 175 g -
V/MRP/21/0019-03 0,71 g/g 1 Maisiņš, 350 g -
Suxibuzone Ecuphar 1.5 g V/DCP/20/0057 Ecuphar NV, Beļģija QM01AA90 horses; ponies Vairāk

Medicinal product information

Pharmaceutical form: granules
International name (active substance): Suxibuzone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Meribel Pharma Parets S.L., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0057-01 1,5 g 18 Paciņa, 3 g -
V/DCP/20/0057-02 1,5 g 60 Paciņa, 3 g -
Veyxyl® LA 20% 200 mg/ml V/NRP/99/1035 Veyx-Pharma GmbH, Vācija QJ01CA04 cattle; pigs; sheep; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Veyx-Pharma GmbH, Vācija
Date of authorisation/renewal: 07-Aug-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 23102020LI (23-Oct-2020)
Labelling text: [PDF] 09112018M (09-Nov-2018)
Summary of product characteristics: [DOCX] 23102020ZA (23-Oct-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/1035-01 200 mg/ml 1 Flakons, 100 ml -

3081 record

© Food and veterinary service · 2026 Cookies policy